Search

Krzysztof Bojanowski

from Santa Paula, CA
Age ~58
Get Report
Also known as:
Krys Bojanowski, Krysztof Bojanowski, Krystof Bojanowski, Krzystof Bojanowski, Krzysztof Bojanowski Dr, Krys Bojanowsai, Bojanowski Krys, Bojanowski Krysztof
Related to:
Hua ZhaoDanielle Schuman, 38Chun Hao, 37
Connected to:
Cezary Bojanowski, 43Gian Bojanovich, 47Jessica Bojanowski, 67Kristin J Bojanowski, 46Lindsay A Bojanowski, 42Maria L Bojanowski, 81Mary A Bojanowski, 94Ryan Bojanovic, 39Sarah Bojanowski, 54Cathy A Bojanski, 61

Krzysztof Bojanowski Phones & Addresses

  • Santa Paula, CA
  • Fremont, CA
  • Richmond, CA
  • Boston, MA
  • Albany, CA
  • 1201 Melville Sq APT 204, Richmond, CA 94804 (562) 435-2695

Work

Position: Building and Grounds Cleaning and Maintenance Occupations

Education

Degree: High school graduate or higher

Resumes

Resumes

Krzysztof Bojanowski Photo 1

Krzysztof Bojanowski

View page

Publications

Us Patents

Compositions And Methods For Treating Angiogenesis-Related Diseases, Wounds And Cosmetic Use Of Components Of , And Methods Of Preparation Thereof

View page
US Patent:
7927634, Apr 19, 2011
Filed:
Apr 13, 2010
Appl. No.:
12/758863
Inventors:
Hui Zhao - Santa Paula CA, US
Krzysztof Bojanowski - Santa Paula CA, US
Fariba Aria - Cupertino CA, US
Reza Mortezaei - Cupertino CA, US
Assignee:
Sunny Biodiscovery, Inc. - Santa Paula CA
International Classification:
A61K 36/00
A61L 15/16
US Classification:
424725, 424446, 424447
Abstract:
Compositions and methods for treating angiogenesis-related diseases and for skin care in mammals is disclosed that includes, as an active pharmaceutical agent, an effective amount of purified extract from , or a fraction or a lyophilizate thereof, or one or more active component contained in said extract.

Composition Comprising Threitol Phosphate And Salts Thereof

View page
US Patent:
8236784, Aug 7, 2012
Filed:
Nov 17, 2009
Appl. No.:
12/620138
Inventors:
Hui Zhao - Santa Paula CA, US
Krzysztof Bojanowski - Santa Paula CA, US
Fariba Aria - Cupertino CA, US
Reza Mortezaei - Cupertino CA, US
Assignee:
Sunny Biodiscovery, Inc. - Santa Paula CA
International Classification:
A61K 31/66
A61K 31/6615
A61K 8/55
C07F 9/09
A61P 17/00
A61P 19/00
A61Q 11/00
A61Q 19/00
A61Q 19/08
US Classification:
514103, 514106, 514129, 424 59, 424 62
Abstract:
This application discloses compositions containing synthetic threitol phosphates, in particular threitol monophosphate, threitol-bis-phosphate, threitol diphosphate, and/or threitol triphosphate. The threitol phosphates are useful in treating wounds, for cosmetic applications, and for bone and periodontal regeneration.

Compositions And Methods For Treating Angiogenesis-Related Diseases, Wounds And Cosmetic Use Of Components Of Angelica Sinensis, And Methods Of Preparation Thereof

View page
US Patent:
20060068032, Mar 30, 2006
Filed:
Sep 24, 2004
Appl. No.:
10/948590
Inventors:
Hui Zhao - Fremont CA, US
Krzysztof Bojanowski - Fremont CA, US
Fariba Aria - Cupertino CA, US
Reza Mortezaei - Cupertino CA, US
Assignee:
Sunny BioDiscovery, Inc. - Santa Clara CA
International Classification:
A61K 36/232
A61K 38/18
US Classification:
424725000, 514002000
Abstract:
Compositions and methods for treating angiogenesis-related diseases and for skin care in mammals is disclosed that includes, as an active pharmaceutical agent, an effective amount of purified extract from , or a fraction or a lyophilizate thereof, or one or more active component contained in said extract.

Anti-Wrinkle Composition

View page
US Patent:
20070166267, Jul 19, 2007
Filed:
Jan 17, 2007
Appl. No.:
11/654406
Inventors:
George Majewski - Redondo Beach CA, US
Amit Shah - Commack NY, US
John Gormley - Midland Park NJ, US
Krzysztof Bojanowski - Santa Paula CA, US
International Classification:
A61K 8/97
A61K 8/64
US Classification:
424070140, 424074000
Abstract:
A composition is disclosed for treating the skin comprising an acylated short chain bioactive peptide and extract product. Also disclosed is a method for topically administering the composition in an amount therapeutically effective to reduce wrinkles by building the dermal fibroblast matrix. The composition may contain dimethylisosorbide or ethoxydiglycol as solubilizing and penetration enhancers for the hydrophobically modified peptide.

Methods And Compositions For The Treatment Of Multiple Sclerosis

View page
US Patent:
20190336468, Nov 7, 2019
Filed:
May 1, 2019
Appl. No.:
16/400360
Inventors:
- Boonton NJ, US
Krzysztof Bojanowski - Santa Paula CA, US
Assignee:
Symbionyx Pharmaceuticals, Inc. - Boonton NJ
International Classification:
A61K 31/34
A61P 25/00
Abstract:
Compositions and methods based on isosorbide esters for the treatment of multiple sclerosis.

Methods Of Using Gm604 In Modulating Als Disease Biomarkers Leading To Prognosis And Therapeutic Treatment For Als Disease

View page
US Patent:
20170157197, Jun 8, 2017
Filed:
Dec 9, 2016
Appl. No.:
15/374950
Inventors:
- Pasadena CA, US
Mark S. Kindy - Tampa FL, US
William Swindell - Athens OH, US
Krzysztof Bojanowski - Santa Paula CA, US
Assignee:
Genervon Biopharmaceuticals, LLC - Pasadena CA
International Classification:
A61K 38/08
Abstract:
Biomarkers are not as commonly used in ALS drug development as in the drug development process for oncology. Biomarkers are important component of the ALS drug development pathway to demonstrate drug effect and target engagement. In a recent Phase 2A double-blind, randomized, placebo controlled clinical trial with GM604 (AKA MNTF, GM6), where ALS patients were treated with six doses of GM604 for two weeks and then continued to be evaluated for disease progression until 10 weeks after cessation of GM604 treatment, it was demonstrated that GM604 can modulate expression of ALS disease related genes, through pathways that bring about homeostasis of pertinent ALS biomarkers. The statistical significance in biomarker changes also correlate with treatment effects in clinical observations. This correlation of disease progression with the modulation of the biomarkers suggest that GM604 can be used effectively in modulating ALS disease biomarkers, and consequently can be used for prognosis of ALS disease progression and therapeutic treatment to slow down ALS disease progression. The biomarker modulation can be a measure of drug efficacy.

Compositions And Methods For Using Esters Of Meroterpenes And Of Other Resveratrol Analogues

View page
US Patent:
20160243069, Aug 25, 2016
Filed:
Oct 19, 2015
Appl. No.:
14/887308
Inventors:
Krzysztof Bojanowski - Santa Paula CA, US
International Classification:
A61K 31/216
A61N 5/06
A61Q 17/04
A61K 8/37
A61K 9/00
A61K 41/00
Abstract:
The invention includes compositions and methods of using meroterpene esters for effectively modulating skin cell function and remediating undesirable skin conditions, as well as the use of such compositions in the treatment of systemic diseases, such as cancer and in nutritional, dermatologic and cosmetic applications, through topical and transbuccal delivery as well as by ingestion, injection or inhalation.
Control profile
Krzysztof Bojanowski from Santa Paula, CA, age ~58 Get Report